» Articles » PMID: 25295631

Protein is an Important but Undervalued Macronutrient in the Nutritional Care of Patients with Cystic Fibrosis

Overview
Specialty General Medicine
Date 2014 Oct 9
PMID 25295631
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Achieving an optimal nutritional status in patients with cystic fibrosis (CF) is important to maintain better pulmonary function, physical performance, and to prolong survival. So far, nutrition care in CF has mainly focused on fat intake and achieving energy balance, but there is increasing information on the clinical importance of muscle maintenance and protein intake in CF.

Recent Findings: Low muscle mass is consistently associated with pulmonary decline, bone mineral loss, and poor survival in CF. High energy and fat intake contributes to an increased prevalence of overweight and obesity in CF. Obesity per se is not related to better lung function in CF and has negative metabolic and clinical consequences, particularly when muscle wasting is present. Protein digestion capacity is severely impaired in CF, but high protein intake is needed and essential amino acid mixtures appear highly anabolic even in those with severe muscle loss.

Summary: Body composition assessment and achieving protein balance in the routine care in CF is important to prevent muscle loss and further improve the clinical and overall outcome of these patients. New approaches are needed to optimize the interaction between high essential amino-acid-rich protein intake and pancreatic enzyme regimen in CF. The optimal level of protein intake needs to be assessed in clinically stable CF patients as well as in those recovering from an acute exacerbation.

Citing Articles

Safety and tolerability of a low glycemic load dietary intervention in adults with cystic fibrosis: a pilot study.

Scully K, Truex L, Brennan A, Fowler R, Sawicki G, Uluer A Front Nutr. 2024; 11:1441201.

PMID: 39385793 PMC: 11462092. DOI: 10.3389/fnut.2024.1441201.


Dietary intake assessment in children with cystic fibrosis using 3-day food diaries: a single-centre study.

Gaschignard M, Beaufils F, Gallet P, Clouzeau H, Menard J, Costanzo A Front Pediatr. 2023; 11:1130792.

PMID: 37228437 PMC: 10203471. DOI: 10.3389/fped.2023.1130792.


Nutritional Care in Children with Cystic Fibrosis.

Mariotti Zani E, Grandinetti R, Cunico D, Torelli L, Fainardi V, Pisi G Nutrients. 2023; 15(3).

PMID: 36771186 PMC: 9921127. DOI: 10.3390/nu15030479.


Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention?.

Trandafir L, Frasinariu O, Tarca E, Butnariu L, Leon Constantin M, Moscalu M Nutrients. 2023; 15(2).

PMID: 36678185 PMC: 9860597. DOI: 10.3390/nu15020314.


Recovery of ΔF508-CFTR Function by Citrate.

Borkenhagen B, Prehm P Nutrients. 2022; 14(20).

PMID: 36296967 PMC: 9610893. DOI: 10.3390/nu14204283.


References
1.
Dillon E, Sheffield-Moore M, Paddon-Jones D, Gilkison C, Sanford A, Casperson S . Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin Endocrinol Metab. 2009; 94(5):1630-7. PMC: 2684480. DOI: 10.1210/jc.2008-1564. View

2.
Vandenbranden S, McMullen A, Schechter M, Pasta D, Michaelis R, Konstan M . Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol. 2012; 47(2):135-43. PMC: 4219484. DOI: 10.1002/ppul.21526. View

3.
Wojewodka G, De Sanctis J, Bernier J, Berube J, Ahlgren H, Gruber J . Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients. PLoS One. 2014; 9(2):e88567. PMC: 3922941. DOI: 10.1371/journal.pone.0088567. View

4.
Lainscak M, von Haehling S, Doehner W, Anker S . The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle. 2012; 3(1):1-4. PMC: 3302984. DOI: 10.1007/s13539-012-0059-5. View

5.
Deutz N, Wolfe R . Is there a maximal anabolic response to protein intake with a meal?. Clin Nutr. 2012; 32(2):309-13. PMC: 3595342. DOI: 10.1016/j.clnu.2012.11.018. View